Microsoft Corporation co-founder, Paul G. Allen, funded a project to create a detailed map of the mouse brain. The project has been completed and is called the 'Allen Brain Atlas'. It is available online, free of charge to the public. The...

The flow of copper in the brain has a previously unrecognized role in cell death, learning and memory, according to research at Washington University School of Medicine in St. Louis. The researchers' findings suggest that copper and its tr...

The Food and Drug Administration today approved a use of the anti-seizure medicine Lamictal(R) (lamotrigine) Tablets for the treatment of one of the most serious forms of epilepsy -- Primary Generalized Tonic-Clonic (PGTC) seizures, al...

Because he discovered a key link between the mind and the body, Kevin J. Tracey, MD, The Feinstein Institute for Medical Research's director and CEO, was invited to speak at "Longevity and Optimal Health: Integrating Eastern and Western Pe...

Daily life requires that people cope with distracting emotions--from the basketball player who must make a crucial shot amidst a screaming crowd, to a salesman under pressure delivering an important pitch to a client. Researchers have now...

Thyroidectomy (removal of the thyroid) has traditionally required multi-day hospitalization. At a minimum, many surgeons advocate overnight observation following this special surgical procedure. While the thyroid is a relatively superficia...

Born of its well-established "Breakthrough Thinking" model and adding to an alreadyimpressive product lineup, Blackstone Medical, Inc. will launch fourinnovative spinal fusion products, and will also reveal details aboutforthcoming pro...

PsychoGenics Inc. Tarrytown, New York has expanded its research collaboration with the High Q Foundation and CHDI Inc. to phenotype transgenic mouse models of Huntington Disease(HD) and evaluate potential therapeutics in those models. HD i...

Ever since scientists first elucidated the molecular mechanisms underlying the pathology and loss of nerve cells in Alzheimer's disease, drug companies have been working to develop drugs which will inhibit the outbreak of this severe form...

The Debiopharm Group (Debiopharm), a global independent biopharmaceutical development company specialising in oncology and serious medical conditions, today announced that it received European orphan drug designation from the Commission of...